# SAB Biotherapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/sab-biotherapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 3 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-15T20:40:40.310485+00:00 | | Last reviewed | 2026-09-15T20:40:40.310485+00:00 | ## Identity - Legal name: SAB Biotherapeutics, Inc. - Display name: SAB Biotherapeutics, Inc. ## Leadership - Alexandra Kropotova: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Andrew Moin: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Christine Hamilton: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Christoph Bausch: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - David Link, MBA: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Eddie J. Sullivan, PhD: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Erick Lucera: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Jay S. Skyler, MD: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Jeffrey G. Spragens: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Katie Ellias: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Lucy To: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Samuel J. Reich: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Scott Giberson: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - William Polvino, MD: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2. - Alexandra Kropotova, MD: Chief Medical Officer. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:3. - Christoph Bausch, PhD: Chief Operating Officer. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:3. - Eddie J. Sullivan, PhD: President. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:3. - Lucy To: Chief Financial Officer. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:3. - Samuel J. Reich: Chief Executive Officer. Valid from: 2026-03-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - SAB Biotherapeutics, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:1. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/sab-biotherapeutics-inc). - alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:2: [SAB Biotherapeutics, Inc. DEF 14A 2025-08-29](https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm). - alpha:evidence:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:3: [SABS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/sab-biotherapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/sab-biotherapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/sab-biotherapeutics-inc) - [JSON-LD](https://registry.alpha.ac/api/public/companies/sab-biotherapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/sab-biotherapeutics-inc` at https://mcp.alpha.ac/mcp